Neoadjuvant chemotherapy for stage II–III breast cancer: a single-center experience

INTRODUCTION: We conducted this study to reflect a single-center experience with the use of neoadjuvant systemic chemotherapy (NAC) for the management of women with operable breast cancer. METHODS: We conducted a retrospective chart review on all women presenting with operable, stage II–III, breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaher, Haidi Abd El, Fathy, Hamada, Abozeid, Mohamed, Faisal, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559473/
https://www.ncbi.nlm.nih.gov/pubmed/37805553
http://dx.doi.org/10.1186/s12957-023-03199-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559473/
https://www.ncbi.nlm.nih.gov/pubmed/37805553
http://dx.doi.org/10.1186/s12957-023-03199-z

Ejemplares similares